A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
United States
AdventHealth, Orlando, Florida Louisiana State University Medical Center New Orleans, New Orleans, Louisiana University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico Stephenson Cancer Center, Oklahoma City, Oklahoma Last updated October 2025